サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463686

北米の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別

North America Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日: | 発行: The Insight Partners | ページ情報: 英文 94 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.41円
北米の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 94 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の新生児スクリーニング市場は、2022年には5億2,155万米ドルと評価され、2030年には10億8,230万米ドルに達すると予測され、2022年から2030年までのCAGRは9.6%で成長すると予測されています。

新生児スクリーニングに対する政府資金の急増が北米新生児スクリーニング市場を後押し

各国の政府は、新生児スクリーニングプログラムに資金を割り当てるようになってきています。先天性疾患や遺伝性疾患は、発見されないまま放置されると深刻な健康合併症や大規模な医療介入を引き起こす可能性があるため、これらのプログラムは子供とその両親の長期的なヘルスケアコストの削減に役立ちます。乳幼児期の健康問題を特定し、それに対処することによって、政府は国民の健康と幸福を増進することができます。このように、新生児スクリーニングは、国民全体の健康を改善し、ヘルスケアシステムの負担を軽減するという、より広範な公衆衛生の目的に沿ったものです。

政府の資金援助はヘルスケアへのアクセスの公平性を促進し、社会経済的地位にかかわらず、すべての人が新生児スクリーニングサービスを受けられるようにします。このような包括性は、異なる人口統計グループ間におけるヘルスケア成果の格差を防ぐため、疾患の早期発見と早期介入に不可欠です。各国政府が新生児スクリーニングに資金援助や政策支援を増やし優先順位をつけ続けているため、新生児スクリーニング市場は世界中で持続的な成長を遂げています。

北米の新生児スクリーニング市場概要

北米の新生児スクリーニング市場は近年著しい成長を遂げています。先天性障害を特定し管理するための早期スクリーニングの重要性に対する両親やヘルスケア専門家の意識の高まりに伴い、新生児スクリーニングサービスに対する需要が大幅に増加しています。さらに、医療技術の向上は新生児スクリーニングの能力を高める上で極めて重要であり、検査室における自動化はスクリーニングの精度、スピード、費用対効果を高めています。これによって医療専門家は、より広範な遺伝・代謝疾患をカバーする徹底的な新生児スクリーニング・パネルを提供できるようになった。有利な法律や規制措置も北米の新生児スクリーニング市場に利益をもたらしています。多くの州や州が新生児スクリーニングの義務化プログラムを実施しており、すべての乳児が出生直後にスクリーニングを受けられるようになっています。例えば、米国では各州が公衆衛生プログラムとして新生児スクリーニングを実施しており、年間約400万人の乳児がこのプログラムの下で出産時にはあまり見られない病気のスクリーニングを受けています。テキサス州保健福祉局は2021年6月、脊髄性筋萎縮症（SMA）の新生児スクリーニングを開始しました。

遺伝子異常や先天性疾患の増加により、新生児スクリーニングの意義が浮き彫りになっています。米国国立衛生研究所は、バッファロー大学の研究者に対し、希少で致死率の高い3つの遺伝性疾患の新生児スクリーニングの精度を大幅に向上させる取り組みとして開発された国際プロジェクトを主導するため、競争率の高いR01助成金を与えました。さらに、NIHのユニス・ケネディ・シュライバー国立小児保健・人間発達研究所は、5年間で380万米ドルの助成金を提供しています。このように、北米の新生児スクリーニング市場は、認知度の向上、技術の進歩、支援政策、先天性疾患の有病率の増加によって拡大しています。

北米の新生児スクリーニング市場の収益と2030年までの予測（金額）

北米の新生児スクリーニング市場のセグメンテーション

北米の新生児スクリーニング市場は、製品タイプ、技術、検査タイプ、エンドユーザー、国によって区分されます。

製品タイプに基づき、北米の新生児スクリーニング市場は試薬・アッセイキットと機器に二分されます。2022年の北米新生児スクリーニング市場シェアは試薬・アッセイキットセグメントが大きいです。試薬・アッセイキットセグメントは、DNAベースアッセイ、免疫アッセイ、酵素アッセイに細分化されます。機器セグメントは、新生児障害スクリーニング機器、パルスオキシメーター、新生児聴覚スクリーニング機器、その他の機器に細分化されます。

技術面では、北米の新生児スクリーニング市場はタンデム質量分析（TMS）、分子アッセイ、免疫アッセイと酵素アッセイ、パルスオキシメトリースクリーニング技術、その他の技術に分類されます。パルスオキシメトリースクリーニング技術セグメントは、2022年に北米の新生児スクリーニング市場で最大のシェアを占めました。

検査タイプに基づき、北米の新生児スクリーニング市場は、乾燥血液スポット検査、聴覚スクリーン検査、重症先天性心疾患（CCHD）検査、その他の検査タイプに分類されます。2022年の北米新生児スクリーニング市場シェアは、乾燥血液スポット検査分野が最大でした。

エンドユーザー別では、北米の新生児スクリーニング市場は病院・診療所と診断研究所に区分されます。病院・診療所セグメントは2022年に北米の新生児スクリーニング市場シェアでより大きな割合を占めました。

国別では、北米の新生児スクリーニング市場は米国、カナダ、メキシコに分類されます。米国は2022年に北米新生児スクリーニング市場を独占しました。

Baebies Inc、Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc、Waters Corpは、北米新生児スクリーニング市場で事業展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の新生児スクリーニング市場：主要産業力学

  • 主な市場促進要因
    • 新生児スクリーニングに対する政府資金の急増
    • 先天性疾患の負担増
    • 新生児疾患の有病率の増加
  • 主な市場抑制要因
    • 新生児スクリーニングの政策と実施における統一性の欠如
  • 主な市場機会
    • 新生児の遺伝子スクリーニング
  • 今後の動向
    • スクリーニングにおける機械学習と人工知能の統合
  • 影響分析

第5章 新生児スクリーニング市場：北米市場分析

  • 北米の新生児スクリーニング市場収益、2022年～2030年

第6章 北米の新生児スクリーニング市場 - 収益と2030年までの予測：製品タイプ別

  • 市場収益シェア、2022年および2030年
  • 試薬およびアッセイキット
  • 機器

第7章 北米の新生児スクリーニング市場 - 収益と2030年までの予測：技術別

  • 市場収益シェア、2022年および2030年
  • タンデム質量分析（TMS）
  • 分子アッセイ
  • 免疫アッセイおよび酵素アッセイ
  • パルスオキシメトリー・スクリーニング技術
  • その他の技術

第8章 北米の新生児スクリーニング市場 - 収益と2030年までの予測：検査タイプ別

  • 市場収益シェア、2022年および2030年
  • 乾燥血液スポット検査
  • 聴覚スクリーニング検査
  • 重症先天性心疾患（CCHD）検査
  • その他の検査タイプ

第9章 北米の新生児スクリーニング市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院および診療所
  • 診断研究所

第10章 北米の新生児スクリーニング市場：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 北米の新生児スクリーニング市場-業界情勢

  • 新生児スクリーニング市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Baebies Inc
  • Medtronic Plc

第13章 付録

図表

List Of Tables

  • Table 1. North America Newborn Screening Market Segmentation
  • Table 2. North America Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 23. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 24. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. North America Newborn Screening Market Segmentation, By Country
  • Figure 2. North America Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in Newborn Screening Market
目次
Product Code: BMIRE00029603

The North America newborn screening market was valued at US$ 521.55 million in 2022 and is expected to reach US$ 1,082.30 million by 2030; it is estimated to grow at a CAGR of 9.6% from 2022 to 2030.

Surging Government Funding for Newborn Screening Fuels the North America Newborn Screening Market

Governments of different countries are increasingly allocating funds for newborn screening programs. These programs help reduce long-term healthcare costs for children and their parents as congenital and genetic disorders could result in severe health complications and extensive medical interventions if left undetected. By identifying and addressing health issues in infancy, governments can enhance the health and well-being of their citizens. Thus, newborn screening aligns with broader public health objectives to improve overall population health and reduce the burden on healthcare systems.

Government funding promotes equity in healthcare access, ensuring that newborn screening services are available to all, regardless of socioeconomic status. This inclusivity is essential for early disease detection and intervention, as it prevents disparities in healthcare outcomes among different demographic groups. As governments continue to prioritize newborn screening through increased funding and policy support, the newborn screening market has been experiencing sustainable growth worldwide.

North America Newborn Screening Market Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-automation in laboratories has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborn for Spinal Muscular Atrophy (SMA) in June 2021.

The rising prevalence of genetic abnormalities and congenital problems has highlighted the significance of newborn screening. The National Institutes of Health has given a researcher from the University at Buffalo a highly competitive R01 grant to lead an international project developed as an effort to significantly increase the accuracy of newborn screening for three rare, frequently fatal genetic diseases. Further, the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH funds the US$ 3.8 million five-year award. Thus, the newborn screening market in North America is increasing with increased awareness, technological advancements, supportive policies, and growing congenital disorder prevalence.

North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

North America Newborn Screening Market Segmentation

The North America newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the North America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger North America newborn screening market share in 2022. The reagents and assay segment kits is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the North America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest North America newborn screening market share in 2022.

Based on test type, the North America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest North America newborn screening market share in 2022.

By end user, the North America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger North America newborn screening market share in 2022.

Based on country, the North America newborn screening market is categorized into the US, Canada, and Mexico. The US dominated the North America newborn screening market in 2022.

Baebies Inc, Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the North America newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - North America Market Analysis

  • 5.1 North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 North America Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Newborn Screening Market - Country Analysis

  • 10.1 North America Newborn Screening Market, Revenue and Forecast To 2030
    • 10.1.1 North America Newborn Screening Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. North America Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PerkinElmer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Waters Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bio-Rad Laboratories Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Masimo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Natus Medical Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Baebies Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medtronic Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms